Altered fractionation of radical radiaton therapy in the management of unresectable non-small-cell lung cancer

Current Oncology

Volumn 7, Issue 2, 2000, Pages 98-109

  Yu, E ^a   Lochrin, C ^a   Dixon, P ^a   Ung, Y C ^a   Gagliardi, A ^a   Evans, W K ^a   Alam, Y ^a   Campling, B ^a   Darling, G ^a   Feld, R ^a   Findlay, B ^a   Goss, G ^a   Graham, I ^a   Gregg, R ^a   Iscoe, N ^a   Kocha, W ^a   Kolin, A ^a   Kotalik, J ^a   Logan, D ^a   Lopez, P ^a   Malthaner, R ^a   Maziak, D ^a   McIvor, A ^a   Miller, J ^a   Okawara, G ^a   Rusthoven, J ^a   Shepherd, F ^a   Steward, D ^a   Urschel, J ^a   Vincent, M ^a   Wenckebach, G ^a   more..

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HUMAN; LUNG NON SMALL CELL CANCER; MEDICAL LITERATURE; META ANALYSIS; PRACTICE GUIDELINE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION RESPONSE; REVIEW; TREATMENT OUTCOME;

EID: 0033839167     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Clinical trials of radiotherapy in hyperbaric oxygen at Portsmouth
2. A controlled clinical trial of Misonidazole in the radiotherapy of patients with carcinoma of the bronchus
3. Large fraction irradiation with or without Misonidazole in advanced non-oat cell carcinoma of the lung: A phase In randomized trial of the Radiation Therapy Oncology Group
4. Split dose radiotherapy: The original premise
5. A re-evaluation of splitcourse technique for squamous cell carcinoma of the head and neck
6. Report of a prospective trial: Split-course versus conventional radiotherapy in the treatment of non-small cell lung cancer
7. A prospective randomized study of various irradiation dose and fractionation schedules in the treatment of inoperable non-oat cell carcinoma of the lung: Preliminary report by the Radiation Therapy Oncology Group
8. Split-dose intensive radiotherapy in the treatment of advanced lung cancer: A randomized study
9. Hyperfractionated radiotherapy of human tumors: Overview of the randomized clinical trials
10. Radiation Therapy Oncology Group 88-08 and Eastern Cooperative Oncology Group 4588: Preliminary results of a phase III trial in regionally advanced unresectable non-small cell lung cancer
11. Hyperfractionated irradiation for non-small cell lung cancer: A phase III clinical trial
12. Prospective randomized trials comparing hyperfractionated radiotherapy with conventional radiotherapy in stage III non-small cell lung cancer
13. Prospective trial of combined hyperfractionated radiotherapy and bronchial arterial infusion of chemotherapy for locally advanced nonsmall cell lung cancer
14. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: Mature data from the randomised multicentre trial
15. Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekendless) in non-small-cell lung cancer
16. Hyperfractionated accelerated radiation therapy for non-small cell lung cancer: Clinical phase I/II trial
17. A randomized phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: Final report of an Australian multi-centre trial
18. Once a week versus conventional daily radiation treatment for lung cancer: Final report
19. Five-year results: Phase III trial of regionally advanced unresectable non-small cell lung cancer, RTOG 8808, ECOG 4588, SWOG 8992
20. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy
21. N2 (clinical) non small cell carcinoma of the lung: Prospective trials of radiation therapy with total doses of 60 Gy by the Radiation Oncology Group
22. Patient-reported short-term and long-term physical and psychologic symptoms: Results of the continuous hyperfractionated accelerated radiotherapy (CHART) randomized trial in non-small-cell lung cancer
23. Strengths and limitations of meta-analysis: Larger studies may be more reliable
24. Do certain countries produce only positive results?. A systematic review of controlled trials
25. Meta-analysis of the literature or of individual patient data: Is there a difference?
26. Discrepancies between meta-analyses and subsequent large randomized, controlled trials
27. Should unpublished data be included in meta-analyses?